KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1109 |
|---|---|
| Product Name | Anti-Candida Albicans HSP91 Homolog Recombinant Antibody |
| Molecular Name | Efungumab |
| Alias | Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab |
| CAS Number | 762260-74-2 |
| Target | HSP91 homolog[Candida albicans] |
| Isotype | scFv-heavy Kappa |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | FCM, IP, ELISA, Neut, FuncS, IF, WB |
| Buffer | PBS, pH7.5 |
| Background | Efungumab (trade name Mycograb) was a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat candidemia (a bloodstream infection caused by pathogenic yeast) in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
